To access this element change to forms mode OFF
Grant Award View - GA207626
Pathogenic membranes as therapeutic drug targets
GA ID:
GA207626
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
4-Jan-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$1,269,456.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Pathogenic membranes as therapeutic drug targets
Purpose:
Resistance of pathogens to drugs continues to emerge and intensify. While host defence peptides (HDPs) are a promising alternative to current drugs, many pathogens have also evolved resistance mechanisms through changes in their cell membrane. This application will apply a range of analytical tools to understand how bacteria change their cell walls in response to HDPs. The results will allow us to design new combination therapies to treat pathogenic infections.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011990
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC
Postcode:
Multiple
Country:
AUSTRALIA